Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Johnson Q. Tran"'
Autor:
Johnson Q. Tran, Marcus O. Muench, Betty Gaillard, Orsolya Darst, Mary M. Tomayko, Rachael P. Jackman
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionAlloimmune responses against platelet antigens, which dominantly target the major histocompatibility complex (MHC), can cause adverse reactions to subsequent platelet transfusions, platelet refractoriness, or rejection of future transplan
Externí odkaz:
https://doaj.org/article/3b3c28585648400299b1f74547b6f09e
Autor:
Rachael P. Jackman, Orsolya Darst, Betty Gaillard, Johnson Q. Tran, Mary M. Tomayko, Marcus O. Muench
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionAlloimmunization is common following platelet transfusion and can result in negative outcomes for recipients such as refractoriness to subsequent transfusions and rejection of transplants. Healthy people do not receive blood transfusions,
Externí odkaz:
https://doaj.org/article/e35437c640944112bb69dcd2d2af3d92
Autor:
Sophia A Blessinger, Johnson Q Tran, Rachael P Jackman, Renata Gilfanova, Jacqueline Rittenhouse, Alan G Gutierrez, John W Heitman, Kelsey Hazegh, Tamir Kanias, Marcus O Muench
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0237106 (2020)
Animal models are vital to the study of transfusion and development of new blood products. Post-transfusion recovery of human blood components can be studied in mice, however, there is a need to identify strains that can best tolerate xenogeneic tran
Externí odkaz:
https://doaj.org/article/11f212ccf65d4fe080434381e0fe432d
Publikováno v:
Vox Sanguinis. 114:207-215
Background and objectives Alloimmunization is common following transfusion with platelet-rich plasma (PRP) and can cause complications such as platelet refractoriness or transplant rejection. It has previously been shown that pathogen reduction of PR
Publikováno v:
Blood Adv
Alloimmunization against platelet-rich plasma (PRP) transfusions can lead to complications such as platelet refractoriness or rejection of subsequent transfusions and transplants. In mice, pathogen reduction treatment of PRP with UVB light and ribofl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c229d54c6a46291e6c08f159dd0adce
https://europepmc.org/articles/PMC7656940/
https://europepmc.org/articles/PMC7656940/
Autor:
Angelo DʼAlessandro, Nareg Roubinian, Grier P. Page, Kelsey Hazegh, Johnson Q. Tran, Marjorie Bravo, Larry J. Dumont, Fang Fang, Rachael P. Jackman, Tamir Kanias, Marcus O. Muench, Lorenzo Bertolone
Publikováno v:
Transfusion
BACKGROUND: Obesity is a global pandemic characterized by multiple comorbidities, including cardiovascular and metabolic diseases. The aim of this study was to define the associations between blood donor body mass index (BMI) and RBC measurements of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c490001ac75509a4d21d52247ccffa0d
https://europepmc.org/articles/PMC7902376/
https://europepmc.org/articles/PMC7902376/
Autor:
John W. Heitman, Jacqueline Rittenhouse, Alan G. Gutierrez, Kelsey Hazegh, Marcus O. Muench, Sophia A. Blessinger, Renata Gilfanova, Rachael P. Jackman, Johnson Q. Tran, Tamir Kanias
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0237106 (2020)
PLoS ONE
PLoS ONE
Animal models are vital to the study of transfusion and development of new blood products. Post-transfusion recovery of human blood components can be studied in mice, however, there is a need to identify strains that can best tolerate xenogeneic tran
Autor:
Sudha Kumari, Vinay Mahajan, James J. Moon, Andrew Huang, Vinayak Viswanadham, Ezana Demissie, Darrell J. Irvine, Shiv Pillai, Johnson Q. Tran, Grace J. Yuen, Faisal Alsufyani
Publikováno v:
J Immunol
PMC
PMC
Copyright © 2019 by The American Association of Immunologists, Inc. The control of cytoskeletal dynamics by dedicator of cytokinesis 2 (DOCK2), a hematopoietic cell-specific actin effector protein, has been implicated in TCR signaling and T cell mig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d946e31aca62bc6a776bab984e73d79a
https://europepmc.org/articles/PMC6920543/
https://europepmc.org/articles/PMC6920543/
Publikováno v:
Transfusion
Background Alloimmunization to platelet-rich plasma (PRP) transfusions can cause adverse reactions such as platelet refractoriness or transplant rejection. Pathogen reduction treatment with ultraviolet light and riboflavin (UV + R) of allogeneic PRP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3962d873d67636351b569dfeefe62f81
https://europepmc.org/articles/PMC7391079/
https://europepmc.org/articles/PMC7391079/
Autor:
Shiv Pillai, Vinay Mahajan, James J. Moon, Johnson Q. Tran, Sudha Kumari, Ezana Demissie, Grace J. Yuen, Faisal Alsufyani, Darrell J. Irvine, Vinayak Viswanadham
The control of cytoskeletal dynamics by Dedicator of cytokinesis 2 (DOCK2), a hematopoietic cell-specific actin effector protein, has been implicated in TCR signaling and T cell migration. Biallelic mutations in Dock2 have been identified in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2c56cd5ed867e3351761167eb401f6